Serum neuregulin -1 (NRG-1) is a potential biomarker for early diagnosis and prediction in refractory schizophrenia
<p>This study tends to identify serum biomarkers for early diagnosis of treatment-resistant schizophrenia (TRS) and prediction of clozapine treatment response, given the heterogeneity of schizophrenia and limitations of antipsychotic treatment.</p> <p>Participants of this prospecti...
-д хадгалсан:
| Үндсэн зохиолч: | Ming Shu (22683656) (author) |
|---|---|
| Бусад зохиолчид: | Qiuying Chen (157606) (author) |
| Хэвлэсэн: |
2025
|
| Нөхцлүүд: | |
| Шошгууд: |
Шошго нэмэх
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Strong correlation (R<sup>2</sup> = 0.734 p < .0001) between Medicare prescriptions per 1,000 persons and Medicaid prescriptions per 1,000 persons among the fifty US states in 2019.
-н: Luke R. Cavanah (19022435)
Хэвлэсэн: (2025) -
Moderate correlation (R<sup>2</sup> = 0.136 p = .0085) between Medicare prescriptions per 1,000 persons and the percentage of white population among the fifty US states.
-н: Luke R. Cavanah (19022435)
Хэвлэсэн: (2025) -
Large state-wide variation (8.6-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2020 <sup>a</sup> indicates ≥1.50 SD (16.0) from the mean (29.9), which is denoted by the dotted line. <sup>b</sup> indicates ≥1.96 SD from the mean.
-н: Luke R. Cavanah (19022435)
Хэвлэсэн: (2025) -
National (A) Medicare prescription rates per thousand Part D enrollees and (B) Medicare spending for clozapine gradually decreased for 2015-2020.
-н: Luke R. Cavanah (19022435)
Хэвлэсэн: (2025) -
Medicare clozapine data analysis.
-н: Luke R. Cavanah (19022435)
Хэвлэсэн: (2025)